Geriatric nutritional risk index as an easy-to-use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab

被引：13

作者：

Hiraoka, Atsushi ^{[1
]}

Kumada, Takashi ^{[2
]}

Tada, Toshifumi ^{[3
]}

Hirooka, Masashi ^{[4
]}

Kariyama, Kazuya ^{[5
]}

Tani, Joji ^{[6
]}

Atsukawa, Masanori ^{[7
]}

Takaguchi, Koichi ^{[8
]}

Itobayashi, Ei ^{[9
]}

Fukunishi, Shinya ^{[10
]}

Tsuji, Kunihiko ^{[11
]}

Ishikawa, Toru ^{[12
]}

Tajiri, Kazuto ^{[13
]}

Ochi, Hironori ^{[14
]}

Yasuda, Satoshi ^{[15
]}

Toyoda, Hidenori ^{[15
]}

Ogawa, Chikara ^{[16
]}

Nishimura, Takashi ^{[17
]}

Hatanaka, Takeshi ^{[18
]}

Kakizaki, Satoru ^{[19
]}

Shimada, Noritomo ^{[20
]}

Kawata, Kazuhito ^{[21
]}

Naganuma, Atsushi ^{[22
]}

Kosaka, Hisashi ^{[23
]}

Matono, Tomomitsu ^{[24
]}

Kuroda, Hidekatsu ^{[25
]}

Yata, Yutaka ^{[26
]}

Ohama, Hideko ^{[1
]}

Tada, Fujimasa ^{[1
]}

Nouso, Kazuhiro ^{[5
]}

Morishita, Asahiro ^{[6
]}

Tsutsui, Akemi ^{[8
]}

Nagano, Takuya ^{[8
]}

Itokawa, Norio ^{[7
]}

Okubo, Tomomi ^{[7
]}

Arai, Taeang ^{[7
]}

Imai, Michitaka ^{[12
]}

Koizumi, Yohei ^{[4
]}

Nakamura, Shinichiro ^{[3
]}

Iijima, Hiroko ^{[17
]}

Kaibori, Masaki ^{[23
]}

Hiasa, Yoichi ^{[4
]}

机构：

[1] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Matsuyama, Ehime 7900024, Japan

[2] Gifu Kyoritsu Univ, Dept Nursing, Ogaki, Japan

[3] Japanese Red Cross Himeji Hosp, Dept Internal Med, Himeji, Hyogo, Japan

[4] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Japan

[5] Okayama City Hosp, Dept Hepatol, Okayama, Japan

[6] Kagawa Univ, Dept Gastroenterol & Hepatol, Takamatsu, Kagawa, Japan

[7] Nippon Med Sch, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan

[8] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan

[9] Asahi Gen Hosp, Dept Gastroenterol, Asahi, Japan

[10] Osaka Med & Pharmaceut Univ, Dept Gastroenterol, Osaka, Japan

[11] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan

[12] Saiseikai Niigata Hosp, Dept Gastroenterol, Niigata, Japan

[13] Toyama Univ Hosp, Dept Gastroenterol, Toyama, Japan

[14] Japanese Red Cross Matsuyama Hosp, Hepatobiliary Ctr, Matsuyama, Ehime, Japan

[15] Ogaki Municipal Hosp, Dept Gastroenterol & Hepatol, Ogaki, Japan

[16] Japanese Red Cross Takamatsu Hosp, Dept Gastroenterol, Takamatsu, Kagawa, Japan

[17] Hyogo Coll Med, Dept Gastroenterol & Hepatol, Nishinomiya, Hyogo, Japan

[18] Gunma Saiseikai Maebashi Hosp, Dept Gastroenterol, Maebashi, Gunma, Japan

[19] Natl Hosp Org Takasaki Gen Med Ctr, Dept Clin Res, Takasaki, Gumma, Japan

[20] Otakanomori Hosp, Div Gastroenterol & Hepatol, Kashiwa, Chiba, Japan

[21] Hamamatsu Univ, Hepatol Div, Dept Internal Med II, Sch Med, Hamamatsu, Shizuoka, Japan

[22] Natl Hosp Org Takasaki Gen Med Ctr, Dept Gastroenterol, Takasaki, Gumma, Japan

[23] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan

[24] St Marys Hosp, Dept Hepatol, Himeji, Hyogo, Japan

[25] Iwate Med Univ, Sch Med, Dept Internal Med, Div Hepatol, Morioka, Iwate, Japan

[26] Hanwa Mem Hosp, Dept Gastroenterol, Osaka, Japan

来源：

HEPATOLOGY RESEARCH | 2023年 / 53卷 / 10期

关键词：

atezolizumab plus bevacizumab; geriatric nutritional risk index; modified albumin-bilirubin grade; nutrition; sarcopenia; MANAGEMENT; GUIDELINES; LENVATINIB; SORAFENIB;

D O I：

10.1111/hepr.13934

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AimThe present study focused on Geriatric Nutritional Risk Index (GNRI), which is based on bodyweight and serum albumin, and known as an easy-to-use nutritional assessment tool in clinical settings, to elucidate the prognostic predictive ability of GNRI in patients treated with atezolizumab plus bevacizumab (Atez/Bev) for hepatocellular carcinoma (HCC). MethodsA total of 525 HCC patients treated with Atez/Bev, based on their classification of unsuitable status for curative treatments and/or transarterial catheter chemoembolization, were enrolled (Child-Pugh A:B:C = 484:40:1, Barcelona Clinic Liver Cancer stage 0:A:B:C:D = 7:25:192:283:18). Prognosis was evaluated retrospectively using GNRI. ResultsAtez/Bev was used in 338 of the present cohort as first-line systemic chemotherapy (64.4%). Median progression-free survival based on GNRI indicating normal, mild decline, moderate decline, and severe decline was 8.3, 6.7, 5.3, and 2.4 months, respectively, whereas median overall survival was 21.4, 17.0, 11.5. and 7.3 months, respectively (both p < 0.001). The concordance index (c-index) values of GNRI for predicting prognosis (progression-free survival/overall survival) were superior to those of Child-Pugh class and albumin-bilirubin grade (0.574/0.632 vs. 0.527/0.570 vs. 0.565/0.629). As a subanalysis, muscle volume loss was observed in 37.5% of 256 patients with computed tomography data available. Along with GNRI decline, frequency of muscle volume loss became progressively larger (normal vs. mild vs. moderate vs. severe = 17.6% vs. 29.2% vs. 41.2% vs. 57.9%, p < 0.001), and a GNRI value of 97.8 was predictive of its occurrence (AUC 0.715, 95% CI 0.649-0.781; specificity/sensitivity = 0.644/0.688). ConclusionThese findings indicate that GNRI is an effective nutritional prognostic tool for predicting prognosis and muscle volume loss complication in HCC patients treated with Atez/Bev.

引用

页码：1031 / 1042

页数：12

共 50 条

[31] Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib
Rimini, Margherita
Kang, Wonseok
Burgio, Valentina
Persano, Mara
Aoki, Tamoko
Shimose, Shigeo
Tada, Toshifumi
Kumada, Takashi
Sho, Takuya
Lai, Eleonora
Celsa, Ciro
Campani, Claudia
Tonnini, Matteo
Tamburini, Emiliano
Hiraoka, Atsushi
Takaguchi, Koichi
Nishida, Naoshi
Iwamoto, Hideki
Itobayashi, Ei
Tsuji, Kunihiko
Sakamoto, Naoya
Ishikawa, Toru
Toyoda, Hidenori
Kudo, Masatoshi
Kawaguchi, Takumi
Hatanaka, Takeshi
Nouso, Kazugiro
Suda, Goki
Cabibbo, Giuseppe
Marra, Fabio
Della Corte, Angelo
Ratti, Francesca
Pedica, Federica
De Cobelli, Francesco
Aldrighetti, Luca
Scartozzi, Mario
Cascinu, Stefano
Casadei-Gardini, Andrea
HEPATOLOGY RESEARCH, 2022, 52 (12) : 1050 - 1059
[32] Toxicity profile, palliative care and hospice utilization of geriatric patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in the veteran health administration
Lucero, Kana
Alkadimi, Munaf
Boyle, Lauren Diaz
Fierro, Maria Elena
Franklin, Kathleen
Mader, Michael
Nooruddin, Zohra
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[33] Serial Changes of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
Murata, Yosuke
Nosaka, Takuto
Akazawa, Yu
Tanaka, Tomoko
Takahashi, Kazuto
Naito, Tatsushi
Matsuda, Hidetaka
Ohtani, Masahiro
Nakamoto, Yasunari
CANCERS, 2024, 16 (13)
[34] Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death
Cabibbo, Giuseppe
Celsa, Ciro
Battaglia, Salvatore
Enea, Marco
Di Maria, Gabriele
Grova, Alessandro
Ciccia, Roberta
Manfredi, Giulia F.
Iavarone, Massimo
Vogel, Arndt
Singal, Amit G.
Reig, Maria
Pinato, David J.
Camma, Calogero
CLINICAL CANCER RESEARCH, 2025, 31 (03) : 543 - 550
[35] GERIATRIC NUTRITIONAL RISK INDEX, PROGNOSTIC NUTRITIONAL INDEX, CONTROLLING NUTRITIONAL STATUS, AND PHASE ANGLE IN CKD5 PATIENTS NOT UNDERGOING DIALYSIS
Han, Byoung-Geun
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
[36] Nutritional screening and mortality in newly institutionalised elderly: A comparison between the Geriatric Nutritional Risk Index and the Mini Nutritional Assessment
Cereda, Emanuele
Pedrolli, Carlo
Zagami, Annunciata
Vanotti, Alfredo
Piffer, Silvano
Opizzi, Annalisa
Rondanelli, Mariangela
Caccialanza, Riccardo
CLINICAL NUTRITION, 2011, 30 (06) : 793 - 798
[37] Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma
Meza-Junco, Judith
Montano-Loza, Aldo J.
Baracos, Vickie E.
Prado, Carla M. M.
Bain, Vincent G.
Beaumont, Crystal
Esfandiari, Nina
Lieffers, Jessica R.
Sawyer, Michael B.
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (10) : 861 - 870
[38] Assessing risk screening methods of malnutrition in geriatric patients; Mini Nutritional Assessment (MNA) versus Geriatric Nutritional Risk Index (GNRI)
Duran Alert, P.
Mila Villarroel, R.
Formiga, F.
Virgili Casas, N.
Vilarasau Farre, C.
NUTRICION HOSPITALARIA, 2012, 27 (02) : 590 - 598
[39] Controlling nutritional status score and geriatric nutritional risk index as a predictor of mortality and hospitalization risk in hospitalized older adults
Rossi, Andrea P.
Scalfi, Luca
Abete, Pasquale
Bellelli, Giuseppe
Bo, Mario
Cherubini, Antonio
Corica, Francesco
Di Bari, Mauro
Maggio, Marcello
Rizzo, Maria Rosaria
Bianchi, Lara
Volpato, Stefano
Landi, Francesco
NUTRITION, 2025, 131
[40] Simplified geriatric nutritional risk index for assessing nutritional status and stratifying mortality risk in patients receiving maintenance hemodialysis
Yamada, Shunsuke
Arase, Hokuto
Taniguchi, Masatomo
Kitazono, Takanari
Nakano, Toshiaki
THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (02) : 253 - 263

← 1 2 3 4 5 →